The treatment group showed lower mortality than controls, and no significant adverse effects were reported
When dose reduction is appropriate Phase 3 trials include provisions for dose reduction: Gastrointestinal adverse events or inadequate oral intake may warrant stepping down to a lower dose level see Retatrutide Side Effects for incidence rates by dose BMI reaching 22 kg/m or below , or perceived excessive weight loss, allows dose reduction Treatment is discontinued at BMI 18.5 kg/m or below How Often and When to Take Retatrutide Injection frequency once weekly by subcutaneous injection, on the same day each week
Regular exercise can enhance antioxidant defenses, including glutathione, by promoting healthy circulation and cellular function
A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomized controlled trials
However, without standardized protocols across providers, the ideal dose varies based on individual goals such as skin brightening, immune support, or detoxification